Overview of Glycinergic Neurotransmission in the Mammalian Nervous System
=========================================================================

Glycine is a major inhibitory neurotransmitter in the brainstem and spinal cord. The glycinergic transmission plays important roles in the reflex and the control of rhythmic motor behaviors such as locomotion and breathing ([@B261], [@B262]; [@B100]; [@B107]; [@B45]), as well as nociceptive processing ([@B17]; [@B2]; [@B115]; [@B309]). Glycine receptors (GlyRs) are also expressed in the retina ([@B259]; [@B120], [@B121]; [@B152]; [@B123]) and various regions of the brain, such as amygdala ([@B200]; [@B201]), hippocampus ([@B196]; [@B50], [@B51]; [@B36]; [@B63]; [@B79]; [@B151]; [@B52]; [@B302]; [@B44]), midbrain ([@B196]; [@B198]; [@B151]), neocortex ([@B196]; [@B151]; [@B256]), to regulate neuronal network excitability. GlyRs are pentameric ligand-gated chloride channels taking the form of α-subunit homopentamers or αβ-subunit heteropentamars. The α-subunit is ligand-binding subunit ([@B26]; [@B105],[@B103]; [@B175]), whereas the β-subunit binds to synaptic gephyrin scaffold consisting of tens to hundreds gephyrin molecules, thereby the αβ heteromeric GlyRs can be accumulated at postsynaptic sites ([@B165]; [@B208]; [@B85]; [@B114]; [@B276]; [@B108]; [@B159]; [@B43]; [@B126]; [@B279]). However, the postsynaptic localization of GlyR is not permanent. GlyRs are constantly exchanged between synaptic sites and extrasynaptic plasma-membrane by means of lateral diffusion, and alterations of the diffusion properties have been considered to be mechanisms involved in the synaptic plasticity ([@B206]; [@B60]; [@B78]; [@B183]; [@B43]; [@B278]). Furthermore, the postsynaptic gephyrin scaffold is involved in regulation of the properties for synaptic plasticity in both glycinergic synapses and GABAergic synapses through interactions with various proteins ([@B90]; [@B289]).

Two possible stoichiometric models of the heteromeric GlyR have been proposed from research using purified GlyR subunits: 3α2β and 2α3β ([@B178]; [@B40]; [@B108]). [@B76] published data supporting 3α2β stoichiometry by single-molecule stepwise photo-bleaching: whereas a homomeric channel of fluorescent protein-tagged α subunits exhibited bleaching by a five-step reduction of fluorescence, a heteromeric channel containing the fluorescent protein-tagged α-subunits exhibited bleaching by a three-step reduction ([@B76]). However, another group proposed the likelihood of the 2α3β stoichiometry based on the observation of antibody bounded receptor consisting of FLAG-tagged α-subunit and His-tagged β-subunit using single-molecule resolution atomic force microscopy ([@B305]). The single-molecular imaging showed that the maximum binding number of antibodies to each of the tag, anti-FLAG antibodies and anti-His antibodies could bind to the receptor up to two and three, respectively. The exact stoichiometry of the αβ GlyR heteromer thus remains a point of contention, and requires further investigation. Although the formation of a homomeric β GlyR has also been hypothesized, biochemical evidence has indicated that β subunits do not form pentamers ([@B106]), and an electrophysiological analysis showed that recombinant expression of only the β subunit in HEK-293 cells does not result in glycine-gated currents ([@B35]).

In contrast to heteromeric GlyR, homomeric GlyRs are mainly distributed in the extrasynaptic area or presynaptic terminal in the brain and spinal cord ([@B288]; [@B145]; [@B307]; [@B293]; [@B67]; [@B80]; [@B173]; [@B135]; [@B176]; [@B15]; [@B52]; [@B256]; [@B302]). The extrasynaptic homomeric GlyRs are activated by ambient glycine or taurine, thereby tonic glycinergic current that contributed to regulation of neuronal excitability both in mature and immature neural tissue is evoked ([@B51]; [@B293]; [@B80]; [@B52]; [@B191]; [@B256]). In contrast to the GlyRs on mature neurons, GlyRs on immature neurons typically induce depolarizing chloride efflux in accordance with the chloride gradient that is opposite to that of mature neurons ([@B248]; [@B87]; [@B29]). The inverted chloride gradient is formed and maintained by Na^+^-K^+^-2Cl^-^ cotransporter (NKCC1), which import chloride ions into the cell. On immature neurons, presynaptic GlyRs facilitate neurotransmitter release through activation of voltage gated calcium channel (VGCC) ([@B288]; [@B145]; [@B307]; [@B79]; [@B176]; [@B302]). Similarly, tonic activation of the extrasynaptic GlyR on the developing immature neurons induced Ca^2+^ transients through VGCCs. The activation of VGCCs have been considered to promote the synaptic accumulation of GlyRs ([@B164]; [@B166]) or to regulate the development of cortical neurons by promoting migration ([@B15], [@B16]). The Ca^2+^ transients may also be involved in the K^+^-Cl^-^ cotransporter type 2 (KCC2) expression ([@B38]; [@B5]). It is generally accepted, the activity of NKCC1 declines with progress of development, whereas activity of KCC2, which establishes the chloride gradient of mature neurons by extrusion of chloride ions, becomes predominant ([@B153]; [@B29]; [@B209]; [@B292]; [@B68]). The KCC2 activity is necessary for glycinergic synapse maturation. Knockdown of KCC2 impaired cluster formation of GlyR α1 subunit (adult-type subunit) and gephyrin in cultured spinal neurons, whereas α2 subunit (neonatal type subunit) cluster formation was not affected by the KCC2 knockdown ([@B269]). In addition to the developmental role, the tonic depolarizing current contributes to regulate the neuronal excitability in immature hippocampus ([@B51]; [@B80]; [@B52]).

The α homomeric GlyR current can be pharmacologically distinguished from that of the αβ heteromeric GlyR by picrotoxin, a GlyR inhibitor: picrotoxin has a 100-fold greater affinity for the α homomeric GlyR than the αβ heteromeric GlyR, such that the α homomeric GlyR is specifically blocked by picrotoxin at low concentrations ([@B243]; [@B198]). These currents can also be distinguished by electrophysiological analysis, because the conductance mediated by α1 or α3 homomeric GlyR is larger than that of α1β or α3β heteromeric GlyR ([@B283]; [@B35]; [@B245]; [@B25]; [@B39]; [@B315]).

In addition to the GlyR agonist, glycine acts as co-agonist of *N*-methyl-[D]{.smallcaps}-aspartate receptor (NMDAR) ([@B149]). The simultaneous binding of glutamate and the co-agonist is required to activate the NMDAR ([@B149]; [@B93]; [@B235]). Although the physiological significance of co-agonist glycine is unclear, the recent works have reported the involvement in induction of LTD ([@B236]), morphogenesis of dopaminergic neurons ([@B264], [@B263]).

Mammalian Glycine Receptor Subunits
-----------------------------------

There exist four GlyR α subunit genes (*GLRA1, GLRA2, GLRA3, GLRA4*) and one β subunit gene (*GLRB*) in humans and rodents ([@B104], [@B103]; [@B175], [@B174]; [@B116]), although the human *GLRA4* is not expressed due to a premature stop codon in this gene, thus human *GLRA4* is pseudogene ([@B273]). Electrophysiological studies on cultured cells expressing mammalian GlyR subunits have shown that the difference in conductance and kinetics between α1β/α3β and α2β, the conductance of α2β is larger than that of the former, activation kinetics of α2 homomeric and α2β heteromeric is slower than α1/α3 containing receptor ([@B283]; [@B35]; [@B245]; [@B25]; [@B197]; [@B39]; [@B315]). The adult mammalian hindbrain and spinal cord predominantly expresses the α1 (*GLRA1*) and β (*GLRB*) GlyR subunits ([@B196]; [@B274]; [@B151]; [@B298]). Hence, it is assumed that heteromeric α1β GlyRs mediate a majority of glycinergic neurotransmission in these matured neural tissues. In this physiological context, it has been shown that glycinergic synaptic transmission is important for the generation of rhythmic motor behaviors. Functional loss of human *GLRA1* due to missense, nonsense, or frame-shift mutation leads to the development of a hyperekplexia syndrome that is characterized by various exaggerated startle responses to unexpected acoustic or tactile stimuli, as well as neonatal apnea ([@B117]; [@B66]; [@B34]). In addition, mutations that are associated with hyperekplexia syndrome have been identified in the GlyR β subunit gene ([@B247]; [@B6]; [@B54]; [@B143]; [@B211]; [@B251]), the gephyrin gene ([@B246]), and the collybistin gene ([@B115]). Furthermore, mutation of the glycine transporter 2 (GlyT2) gene (*slc5a6*) leads to a reduction in presynaptic glycine release and also produces hyperekplexia ([@B117]).

Also α3 subunits are expressed in the spinal cord as heteromeric GlyRs. The α3 subunit distribution is restricted to the superficial layer of the adult dorsal horn of the spinal cord ([@B115]), and the α3 subunit is involved in nociceptive processing by modulating the excitability of projection neurons that relay nociceptive input from peripheral afferents ([@B115], [@B119]; [@B309]). Prostaglandin E2, an important inflammatory mediator, induces protein kinase A-dependent phosphorylation at Ser346 of the α3 subunit to depress glycinergic synaptic transmission and facilitate inflammatory pain ([@B2]; [@B115]; [@B309]). Although the α3 knockout mice exhibited neither morphological abnormality nor neuro-motor phenotype, the prostaglandin E2 induced pain sensitization was abolished in the α3 knockout mice ([@B115]). Hence the α3 subunit may therefore be a promising target for the regulation of inflammatory pain. In fact, cannabinoids that potentiate α3 subunit exhibited analgesic effect to chronic inflammatory pain without psychoactive side effect ([@B303]). The α3 phosphorylation induced conformational change specifically on glycine binding site of the α3 subunit, because the serine residues is not conserved at the equivalent position of the α1 subunit ([@B115]; [@B113]). The specific conformational change may be a help to develop other type specific drugs potentiating the phosphorylated α3 subunit. Thus, the glycinergic synaptic transmission in spinal cord is mediated by the α1β and α3β heteromeric receptor, and synaptic transmission is an attractive for the development effective remedies. In addition to the pain regulation in spinal cord, changes in the activity of hippocampal α3 subunit are also associated with temporal lobe epilepsy ([@B80]; [@B180]; [@B302]).

The α2 subunit mRNA encoded by *GLRA2* gene is predominantly expressed in the developing spinal cord, and then the α2 subunit is largely replaced by the α1 subunit in this regions within 2 weeks after birth in mice ([@B175]; [@B196]; [@B296]; [@B274]; [@B187]). Functional α2 homomeric GlyRs also found in embryonic immature cortex neurons ([@B87]; [@B308]). Although a previous study using α2 knockout mice showed no morphological or molecular alterations in nervous system development ([@B308]), recent analysis in newly established α2 knockout mice indicated that the α2 subunit contributes to several neural development process, such as tangential migration in developing cortex ([@B15]), cerebral cortical neurogenesis ([@B16]), morphogenesis and synaptogenesis of somatosensory cortical neuron ([@B216]). The importance of α2 subunit in development and maturation of brain was also underscored by the recent identification of a micro-deletion and two mutations in GLRA2 gene from patients with autism spectrum disorder ([@B242]; [@B241]).

After the developmental switching in the spinal cord, α2 and α3 subunits are still expressed as the predominant subunits in some regions of adult brain such as hippocampus and frontal cortex; in these regions the GlyRs contribute to regulation of neural excitability and synaptic plasticity ([@B50]; [@B277]; [@B314], [@B313]; [@B79]; [@B173]; [@B10]; [@B151]). GlyR β subunit mRNA was abundantly detected throughout the embryonic and adult brain, from olfactory bulb to spinal cord ([@B92]; [@B196]). However, a recent immunohistochemical study using a novel monoclonal antibody to the GlyR β subunit exhibited distinctive punctate staining of the β subunit at synaptic sites only in spinal cord, brainstem, midbrain, olfactory bulb, and retina of adult mice ([@B298]). In contrast to these regions, only weak diffuse immunostaining signals were detected in the hypothalamus, the cerebellum, the hippocampus and the neocortex of adult mice ([@B298]). These observations suggest that most of GlyRs in adult brain are extrasynaptic homopentamer, as presented in previous studies about hippocampal GlyR ([@B50]; [@B313]; [@B10]). It has been suggested that the tonic inhibition by the neocortex GlyRs have antiepileptic effect ([@B51]; [@B163]; [@B313]; [@B271]). Epilepsy upregulated the expression of high-affinity GlyR through RNA editing in GlyR mRNA; this high-affinity GlyR may facilitate tonic inhibition to suppress the epileptic activity ([@B80]).

In other region of adult brain, GlyRs are considered to participate in drug addiction. Studies using rodent models have revealed that some of the cortex GlyRs are involved in the behavioral effect of ethanol, such as a motor incoordination or a hypnosis ([@B244]; [@B306]; [@B31]; [@B202],[@B203]; [@B1]), and in the ethanol preference ([@B32]). Ethanol increases extracellular dopamine levels in nucleus accumbens of the brain reward system through enhancement of the accumbal GlyR activity ([@B214]; [@B213]; [@B191]). The accumbal GlyRs are also involved in the dopamine-elevating effects of tetrahydrocannabinol and nicotine in the nucleus accumbens ([@B150]). Since dopamine elevation is a basis of drug addiction, the accumbal GlyR could be therapeutic targets of the addiction of ethanol or nicotine.

In addition to the expression within the brain, immunolabeling studies have demonstrated that all α subunits are also expressed in retina, especially in inner plexiform layer (IPL), with subunit -specific expression patterns ([@B259]; [@B120], [@B121]; [@B152]; [@B123]; [@B297]; [@B312]), suggesting that different GlyR α subunits may be involved in different levels of visual processing ([@B295]). Monoclonal antibody against the GlyR β subunit revealed that the β subunits were almost completely colocalized with GlyR α1-3 subunits and gephyrin in the IPL of mouse retina, however, GlyR α4 subunit did not show the highly colocalization with the β subunits ([@B298]). Thus, most of the retinal GlyR are αβ heteromeric receptor. The physiological role of these glycinergic synapses have been investigated by pharmacological and genetic approaches. For example, strychnine, a specific GlyR blocker, mediated blockade of glycinergic feedback pathway that from neuron in IPL to photoreceptor cell reduced the amplitudes of light-evoked response in both ON and OFF bipolar cells, indicating that the feedback pathway regulates signal propagation in the distal retina ([@B146]). Genetic manipulations of GlyR α subunits *in vivo* have informed the significance of GlyR α subunit expression in the retina. Inhibitory glycinergic transmission between amacrine and bipolar cells of the retina is absent in *GLRA1*-deficient mice ([@B142]), and the frequency of spontaneous glycinergic input to A-type ganglion cells is also significantly reduced in the *GLRA1*-deficient retina ([@B192]). A study of *GLRA2* knockout mice revealed that α2-containing GlyRs are involved in glycinergic input to group II wide-field amacrine cells ([@B193]). In the *GLRA2*-deficient retina, glycine-evoked currents are also reduced in MA-S5 and ON-starburst amacrine cells, suggesting that the α2 subunit is also involved in information processing by the amacrine cells. In *GLRA3* deficient mice, spontaneous glycinergic currents are absent in AII amacrine cells ([@B297]), additionally suggesting a role for the α3 subunit in these cells. In addition, α2 and α3 subunits enhance the excitatory center response of retinal receptive fields through modulation of local receptive field interactions ([@B225]). Since the kinetics of glycinergic transmission differ according to α subunit type, signaling via different GlyRs may facilitate the complex regulation of retinal neuronal networks in visual processing.

Mammalian Glycine Transporters
------------------------------

Two glycine transporters have been identified in the mammalian CNS: glycine transporter 1 (GlyT1) and 2 (GlyT2). Both of these transporters belong to the Na^+^/Cl^-^ dependent transporter family and mediate the uptake of glycine from the extracellular space into the cytosol ([@B83]; [@B30]). GlyT1 is primarily expressed in glial cells throughout the CNS ([@B83]; [@B30]). Glycinergic transporter 1 regulates glycine concentrations in the synaptic cleft of glycinergic synapses and glutamatergic synapses, where glycine acts as an essential co-agonist of NMDAR ([@B83]; [@B30]). GlyT1 knockout mice display respiratory insufficiency as a result of elevated synaptic glycine and over-activation of GlyRs in the respiratory pathway ([@B100]). Alternatively, GlyT2 is expressed in glycinergic neurons and mainly localizes to the presynaptic terminal. GlyT2 facilitates the uptake of glycine released into the presynaptic terminal in order to limit the extent of neurotransmission and allow the recycling of glycine for future synaptic transmission. Accordingly, GlyT2 knockout mice display attenuated glycinergic synaptic transmission ([@B101]).

Glycinergic Neurotransmission in Non-Mammalian Systems
======================================================

Many investigations to reveal the physiological role of glycinergic synapse have been conducted in the mammalian model animals or human; however, non-mammalian vertebrates have been used for investigation the physiological roles of glycinergic synapse in locomotive behaviors ([@B75]; [@B107]; [@B170]; [@B252]). Most teleosts have Mauthner cells (M-cells), which are paired large neurons found in their hindbrain ([@B77]; [@B318]). The M-cell is activated by auditory input, and the M-cell firing triggers fast escape behaviors ([@B168]; [@B167]). Both excitatory (e.g., glutamatergic) and inhibitory (e.g., glycinergic and GABAergic) synapses are formed on dendrites and soma of the M-cell ([@B170]). In goldfish, glycinergic input to M-cells was enhanced by tetanization of the auditory pathway ([@B171]) or repeated sound stimulation ([@B226]). Glycinergic synaptic transmission reduces M-cell excitability by countering concurrent excitatory synaptic input ([@B170]; [@B59]). Thus, the plasticity of the glycinergic synapse has been shown to regulate auditory conditioning of the escape response ([@B226]). Recently, zebrafish (*Danio rerio*) have also been used as a model for investigating the physiological roles of glycinergic neurotransmission ([@B57]; [@B129]; [@B72]; [@B250]; [@B215]). In this review, we will describe advances in both forward and reverse genetic approaches as well as visualization techniques that have proven helpful for the study of the glycinergic synapse in zebrafish.

Zebrafish Glycine Receptors
---------------------------

In total, zebrafish express five α subunits (*glra1*, *glra2*, *glra3*, *glra4a* and *glra4b*) and two β subunits (*glrba* and *glrbb*) ([@B128]). Four GlyR α subunits (αZ1, αZ2, αZ3, and αZ4) and two β subunits (βa/βZ and and βb) were initially reported in zebrafish ([@B65]; [@B138],[@B139],[@B140]; [@B129]). Although αZ2 was originally thought to encode a GlyR α2 subunit ([@B138]), the gene was subsequently reclassified as a second α4 subunit in a more detailed phylogenetic analysis ([@B139]). Thus, αZ2 was designated *glra4a*. Phylogenetic analyses have suggested that αZ1, αZ3, and αZ4 subunits are orthologs of the mammalian α1, α3, and α4 GlyR subunits, respectively ([@B139]); thus, these subunits have been referred to as the zebrafish GlyRα1, GlyRα3, and GlyRα4b. Of note, the existence of distinct orthologs of a mammalian gene is common in the zebrafish genome due to suspected whole genome duplication during fish evolution ([@B7]). The spatial expression of GlyR genes has been examined using *in situ* hybridization (**Table [1](#T1){ref-type="table"}**). Although the spatial expression patterns of *glra2* and *glra3* remain to be determined, quantitative PCR analysis of developing zebrafish embryos (24--72 hpf) has revealed the temporal expression patterns for these genes: *glra1*, *glra3*, and *glra4a* were observed at 24 hpf, whereas *glra2* expression was not induced until 32 hpf ([@B94]). Moreover, the expression levels of *glra1, glra2, and glra4a* were noted to steadily increase during development, while the expression of *glra3* subsided after 48 hpf ([@B94]). Knock down experiments using antisense morpholino oligo (MO) have reported the specific involvement of *glra4a* in the differentiation of spinal interneurons ([@B204]).

###### 

Spatial expression pattern of glycine receptor subunits

  Gene     Stage    Expressing tissue                                                                                                                              Reference
  -------- -------- ---------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  glra1    24 hpf   Telencephalon, posterior part of midbrain midbrain-hindbrain boundary reticular neurons of hindbrain, spinal neurons, eye primordium           [@B69] [@B129]
           48 hpf   Spinal neurons                                                                                                                                 [@B204]
           52 hpf   Telencephalon, Diencephalon, Midbrain, Hindbrain, Spinal cord                                                                                  [@B69]
                                                                                                                                                                   
  glra2             Remain to be determined                                                                                                                        
                                                                                                                                                                   
  glra3             Remain to be determined                                                                                                                        
                                                                                                                                                                   
  glra4a   24 hpf   Subset of cells in the telencephalon, rhombic lip, midbrain-hindbrain boundary region, reticular neurons of hindbrain, spinal neuron, somite   [@B139] [@B204]
           52 hpf   Olfactory pit, midbrain, reticular neurons of hindbrain, somite                                                                                [@B139]
                                                                                                                                                                   
  glra4b   24 hpf   Rhombensephalic lip, midbrain hindbrain boundary region                                                                                        [@B139]
           52 hpf   Ganglion cell layer of retina                                                                                                                  [@B139]; [@B125]
                                                                                                                                                                   
  glrba             Remain to be determined                                                                                                                        
                                                                                                                                                                   
  glrbb    24 hpf   Reticular neurons of hindbrain, spinal neuron                                                                                                  [@B129]

The Advantages of Zebrafish as a Vertebrate Model
-------------------------------------------------

Zebrafish offer several advantages as a model for vertebrate development. First, zebrafish quickly reach sexual maturity (within 3 months), and the adult zebrafish lay 100--200 eggs twice a week, such that fertilized eggs are readily available throughout the year with a relatively low cost, because a large number of zebrafish can be maintained in smaller space compared to model mammals. Second, zebrafish embryos are optically transparent, and their development progresses rapidly at 28.5°C ([@B160]). These characteristics are helpful for developmental studies *in vivo*. Indeed, *in vivo* imaging of events such as synapse formation and subcellular CaMKII translocation has been achieved through the use of green fluorescent protein tagging in zebrafish embryos ([@B97]; [@B224]). Moreover, the transparency of early zebrafish embryos has enabled the *in vivo* study and manipulation of neural activity ([@B70]; [@B11]; [@B317]; [@B266]; [@B220]). While the transparency of the zebrafish embryo is progressively diminished by the formation of melanophores after 24 hpf, 1-phenyl 2-thiourea (PTU) is a widely used agent to prevent the pigment formation ([@B154]). Alternatively, because it is not feasible to grow zebrafish into adulthood in the presence of PTU, a pigment-deficient mutant known as *casper* is now available, and facilitates the *in vivo* visualization and manipulation of neural activity in adult zebrafish ([@B299]). Third, zebrafish are suitable for electrophysiological analyses. The activity of neurons and muscles can be recorded using standard patch-clamp and extracellular recording techniques during most stages of zebrafish development ([@B109]; [@B181], [@B182]; [@B249]; [@B74]; [@B255]; [@B272]; [@B127]; [@B162]; [@B86]; [@B205]; [@B285]). Finally, the high-efficient mutagenesis and transgenesis are available in zebrafish, as discussed in a later section of this review.

In addition to the usefulness in developmental study, zebrafish is also valuable model for high-throughput screening of novel drugs ([@B238]; [@B98]; [@B188]). The high-throughput screening using mutant zebrafish model of human disease have identified novel compound that potentially ameliorate the phenotype associated with the mutation ([@B239]; [@B46]; [@B233]; [@B155]; [@B237]; [@B22]).

The Development of Locomotive Behavior
--------------------------------------

Zebrafish exhibit three distinct behaviors during embryogenesis: spontaneous coiling, touch-evoked escape contractions, and swimming. Spontaneous coiling appears after 17 hpf, and consists of side-to-side alternating contractions of the axial muscles ([@B254]; [@B72]; [@B240]). The frequency of spontaneous coiling reaches a peak of 0.3--1 Hz at 19 hpf and gradually declines to less than 0.1 Hz by 26 hpf. After 21 hpf, zebrafish embryos respond to tactile stimuli with escape contractions that typically consists of two-to-three rapid, alternating contractions of the axial muscles ([@B254]; [@B129]). By 28 hpf, tactile stimuli initiate swimming ([@B254]). The frequency of swimming contractions reaches 30 Hz at 36 hpf, which is comparable to the frequency of tail contraction in adult zebrafish ([@B41]). Thus, the neural network regulating swimming is functionally matured within 1.5 days of development. Interestingly, head-removed embryos transected at somites 5--7 are capable of responding to touch with an initial tail flip, although swimming fails to follow in most cases ([@B72]). Indeed, detailed observations suggest that the spinal cord can initiate touch responses, while supraspinal input is necessary for swimming. The spinal cord region located between somites 5--10 somite appears to be responsible for spontaneous coiling ([@B240]). Given this knowledge, a variety of *in vivo* and *ex vivo* manipulations are possible in zebrafish.

Mutagenesis and Transgenesis in Zebrafish
-----------------------------------------

Mutagenesis for the forward genetic screening of zebrafish mutants was first established in the early 1990's ([@B218]), and two large-scale *N*-ethyl-*N*-nitrourea (ENU)-based mutagenesis projects were completed in Tübingen, Germany and Boston, USA by 1996. These screens identified more than 4,000 mutants, including motility defective mutants, caused by the dysfunction of glycinergic neurotransmission.

Additionally, more comprehensive ENU-based mutagenesis project named "Zebrafish Mutation Project (ZMP)" was launched in 2011. ZMP identified potentially disruptive mutations in more than 38% of all known zebrafish protein-coding genes ([@B158]). The forward genetic approach provides an opportunity to identify novel genes participating in the investigating subject. The growing list of disruptive mutated alleles will be a valuable resource both for fundamental and clinical research to reveal the interested gene function.

On the other hand, reverse genetic approaches has also been applied to zebrafish biology. Targeting-induced local lesions in genomes (TILLING) has been introduced to zebrafish as the first available reverse genetics method ([@B300]). TILLING is a combinational method of chemical-induced mutagenesis and high-throughput screening; accordingly, TILLING can generate not only loss of function mutations, but also unexpected mutations due to non-directional missense mutagenesis ([@B300], [@B301]; [@B212]). However, TILLING is time-consuming and less effective for intron-rich genes due to a decreased chance of obtaining null or hypomorphic alleles ([@B281]). Subsequently, Zinc finger nucleases (ZFNs) ([@B73]; [@B207]; [@B88]; [@B257]) and transcription activator-like effector nucleases (TALEN) ([@B258]; [@B27]; [@B42]; [@B61]) were introduced to zebrafish genetics as targeted mutagenesis methods. ZFNs utilize an array of zinc finger DNA-binding motifs that bind to specific DNA triplet sequences ([@B290]; [@B48]). However, the exact DNA binding specificity of ZFNs has not been completely resolved ([@B48]) and thus each ZFN construct requires careful design and screening of its target DNA-binding zinc finger motifs. Alternatively, TALEN DNA binding specificity is more predictable ([@B210]). The DNA-binding motif of TALEN is composed of repeated modules, where each module independently binds to a specific single nucleotide through repeat variable di-residues in a 1:1 manner. Thus, each module is a functional unit for the recognition of DNA sequences ([@B33]; [@B217]). This simple rule of nucleotide recognition has made TALEN more popular than ZFN for zebrafish genetics.

More recently, the clustered regularly interspaced palindromic repeats/CRISPR-associated 9 (CRISPER/Cas9) method was applied to zebrafish as a surprisingly simple and effective method. CRISPR and Cas are involved in bacterial adaptive immunity against the invasion of foreign nucleic acids derived from exogenous plasmids or bacteriophages ([@B23]; [@B95]; [@B133]). In type II CRISPR/Cas systems, Cas9 nuclease is guided to the target site by two RNA molecules, tracrRNA and crRNA. Alternatively, the use of a single chimeric guide RNA, generated by fusing the 3′ end of a crRNA to the 5′ end of a tracrRNA, has been used to guide Cas9 to its target site ([@B147]). Thus, instead of the need to design a DNA binding domain consisting of several 10--100s amino acids as in the case of ZFN and TALEN, a single small guide RNA can be used in CRISPR/Cas9. Codon-optimized Cas9 with guide RNA efficiently induces target sequence-specific genome modification in humans and mammals ([@B55]; [@B184]; [@B185]; [@B195]). In zebrafish, CRISPR/Cas9 produces targeted gene lesion with a similar efficiency to that of TALENs ([@B49]; [@B137]). Furthermore, the mutagenesis efficiency was improved with zebrafish codon optimized Cas9 ([@B144]; [@B186]). The off-target effects of the CRISPR/Cas9 method are reported to be quite limited ([@B49]; [@B134]; [@B137]; [@B144]), although some studies in cultured cells have reported high off-target mutagenesis ([@B91]; [@B136]). This complication can be resolved through back-crossing with wild-type zebrafish. CRISPE/Cas9 system is able to introduce not only an in-del mutation leading to gene knockout, but also exogenouse coding DNA in site specific manner ([@B14]; [@B161]; [@B132]). The site specific insertion allows researchers to substitute any nucleotides or amino acids, or to tagging any protein with fluorescent protein or epitope tag.

Other than the knockout technologies, MO injection into fertilized eggs has been widely used as gene knockdown method ([@B223]). However, in some cases MO-induced phenotypes (morphant) were not observed to correspond with equivalent mutants generated by ZFN and TALEN ([@B169]). Phenotypic discrepancies between morphants and mutants may be due to the off-target effects of MO ([@B169]). Alternatively, genetic compensation induced by deleterious mutation has also been reported as a cause of phenotype variation between morphants and mutants, as compensatory gene upregulation is not typically observed in MO-injected embryos ([@B253]). Regardless of the cause of phenotypic discrepancy, antisense MOs should be used with meticulous care, and consider dose dependency as well as the implementation of proper positive and negative controls.

Transposon or retroviral methods have also been used to generate transgenic zebrafish ([@B64]; [@B157]; [@B81]; [@B291]; [@B13]) with improved efficiency ([@B64]; [@B157]; [@B81]; [@B275]; [@B291]). This increased efficiency has facilitated the use of the yeast GAL4/UAS system ([@B260]; [@B141]; [@B270]; [@B13]; [@B112]). GAL4, a yeast transcriptional activator, is capable of binding UAS sequences and driving the expression of downstream genes ([@B37]; [@B12]). Thus, a gene of interest can be expressed in any tissue by crossing UAS transgenic zebrafish with tissue-specific GAL4 driver transgenic zebrafish. Recently, various GAL4 driver transgenic zebrafish have been established using the Tol2 transposon-mediated enhancer trap method ([@B12]; [@B156]). In fact, the GAL4/UAS system has proven to have great utility for *in vivo* imaging and the manipulation of neural activity in zebrafish ([@B70]; [@B11]; [@B317]; [@B266]; [@B220], [@B219]). However, GAL4/UAS systems also have a disadvantage. It has been reported that the methylation at CpG nucleotides in the UAS sequences could silence the transgene expression in zebrafish that is offspring of the founder ([@B99]; [@B4]; [@B234]). Although tryptophan repressor (TrpR) and its upstream activation sequence (tUAS) was proposed as an alternative gene expression system to overcome the silencing effect of Gal4/UAS, TrpR/tUAS system gave toxic effect to developing zebrafish may be due to strong transcriptional activity or toxic effect of TrpR protein ([@B282]). Four distinct Gal4 binding sites that placed in tandem (4x nr UAS) drove high levels of reporter expression with significantly less susceptible to the methylation compare to fourteen tandem copies of UAS ([@B4]). Therefore, the fewere non-repetitive UAS sequence could be useful to circumvent the silencing by the methylation.

The Non-invasive Imaging of Neuronal Excitability
-------------------------------------------------

Inhibitory glycinergic and GABAergic synaptic inputs critically regulate neuronal excitability. Electrophysiological techniques are available for the monitoring of single neuron excitability through membrane potential and synaptic current recordings; however, it is difficult to investigate network excitability using this approach. An alternative approach is the monitoring of Ca^2+^ transients as a surrogate of excitability. To this end, genetically encoded calcium indicators have been used for Ca^2+^ imaging in zebrafish ([@B220]). GCaMP, the most widely used genetically encoded calcium indicator, is a fusion protein of circularly permuted EGFP, calmodulin, and calmodulin-interacting M13 peptide ([@B18]; [@B222]). Although the fluorescence intensity of circularly permuted EGFP is very low, conformational changes induced by Ca^2+^ binding to calmodulin lead to the enhancement of fluorescence intensity and improved detection. The sensitivity of this method has been improved by the generation of GCaMP variants, which are now available for research use ([@B228]; [@B284]; [@B286]; [@B3]; [@B53]; [@B219]). [@B220] have successfully used this technique to visualize the alternating activation of spinal motor neurons during spontaneous coiling, and neural activity in the optic tectum during prey capture behavior ([@B219]).

Zebrafish Motility Defect Mutants
=================================

In the Tübingen screen, 166 mutants showing motility defects between 48 and 60 hpf were identified ([@B102]). Among them, 63 mutants were assumed to be muscle-defective based on the simple observation of actin-myosin organization (birefringence intensity) under polarized light ([@B84]). Mutations in dystrophin, laminin, titin, Hsp90 and the cognate co-chaperone Unc45b were identified in this manner ([@B24]; [@B82]; [@B111]; [@B280]; [@B122]; [@B110]). The other 103 mutants with normal muscle structure were divided into two groups: locomotion abnormal and reduced motility ([@B102]), and assumed to have impairments in the nervous system, neuromuscular junction (NMJ), or muscular functional components. Electrophysiological analyses have been useful in delineating the exact cause of each abnormality. For example, electrophysiological recordings from the *accordion* (*acc*) mutant, a locomotion abnormal mutant, revealed normal neuronal outputs and thus implicated deficits in the functional components of the muscle ([@B130]). In the *atp2a1* mutant, it was determined that the simultaneous contraction of the bilateral trunk muscles results from the impaired clearance of cytosolic Ca^2+^ by the sarcoplasmic reticulum Ca^2+^-ATPase SERCA1 ([@B96]; [@B130]). Several other muscle mutants (*relaxed*, *relatively relaxed*) have exhibited defects in excitation-contraction coupling ([@B268], [@B267]; [@B316]; [@B131]).

Six abnormal locomotive mutants (*bandoneon*, *ziehharmonika*, *bajan*, *diwanka*, *quetschkommode*, and *expander*) were previously compared with the *acc* mutant ([@B102]). In contrast to *acc*, electrophysiological recordings from the *bandoneon* (*beo*) mutant showed aberrant, arrhythmic fluctuations in response to tactile stimulation, indicating a defect in CNS output ([@B129]). As will be described in detail, a molecular genetic study revealed that alteration of the *glrbb* gene is responsible for the *beo* mutant, and thus *beo* exhibits defects in glycinergic synaptic transmission ([@B129]). Of note, *beo* is the only known *acc* subgroup mutant with dysfunctional glycinergic transmission (**Table [2](#T2){ref-type="table"}**).

###### 

Accordion mutants.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Mutant              Responsible gene                                                                    Alleles   Substitutions    Cause of defective behavior                                                                                                                                      References
  ------------------- ----------------------------------------------------------------------------------- --------- ---------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
  *accordion*\        Sarcoplasmic reticulum Ca^2+^ ATPase SERCA1 gene (*atp2a1*) on chromosome 3         dta5\     G598V\           Impaired clearance of cytosolic Ca^2+^ in muscle cells.                                                                                                          [@B102]; [@B96]; [@B130]; [@B199]; [@B229]
  *acc*                                                                                                   mi25i\    I97N\                                                                                                                                                                             
                                                                                                          mi289a\   T848I\                                                                                                                                                                            
                                                                                                          tc249a\   Unknown\                                                                                                                                                                          
                                                                                                          ti284a\   Unknown\                                                                                                                                                                          
                                                                                                          tm286\    Unknown\                                                                                                                                                                          
                                                                                                          tn218b\   Unknown\                                                                                                                                                                          
                                                                                                          tp72x\    Unknown\                                                                                                                                                                          
                                                                                                          tq206\    S766F\                                                                                                                                                                            
                                                                                                          ty20      Unknown                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                      

  *bajan*\            Choline acetyltransferase gene (*chat*) on chromosome 13                            tf247     IVS2-2A \> C     Attenuated transmission at neuromuscular junction                                                                                                                [@B102]; [@B294]
  *baj*                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                      

  *bandoneon*\        GlyR β subunit gene (*glrbb*) on chromosome 14                                      tp221\    Y79X\            Dysfunction of glycinergic synaptic transmission on spinal motor neurons due to defect in clustering formation of glycine receptor at synapses                   [@B102]; [@B129]; [@B94]
  *beo*                                                                                                   tw38f\    L255R\                                                                                                                                                                            
                                                                                                          ta86d\    Y79X\                                                                                                                                                                             
                                                                                                          ta92\     K343X\                                                                                                                                                                            
                                                                                                          tm115\    Q87X\                                                                                                                                                                             
                                                                                                          tf242\    Y79D\                                                                                                                                                                             
                                                                                                          tu230\    Allele lost\                                                                                                                                                                      
                                                                                                          mi106a    R275H                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                      

  *diwanka*\          Procollagen lysin 2- oxoglutarate 5-dioxygenase 3 gene (*plod3*) on chromosome 23   ts286\    Q608X\           Defect in primary motoneuron projection.\                                                                                                                        [@B102]; [@B310]; [@B311]; [@B265]
  *diw*                                                                                                   tv205a\   IVS4-2A \> G\    All primary motor axons fail to exit the spinal cord                                                                                                             
                                                                                                          tz290     W447X                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                      

  *expander*\         Unknown                                                                             tu12      Unknown          Unknown                                                                                                                                                          [@B102]
  *exp*                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                      

  *quetschkommode*\   Dihydrolipoamide branched chain transacylase E2 (*dbt*) gene on chromosome 22       ti274     IVS6 + 1G \> A   Abnormal output from CNS. The abnormality may be result of decrease in neurotransmitter glutamate level within CNS due to dysfunction of amino acid metabolism   [@B102]; [@B89]
  *que*                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                      

  *ziehharmonika*\    Acetylcholine-esterase gene (*ache*) on chromosome 7                                sb55\     S226N\           Reduction of acetylcholine receptor clustering at neuromuscular junction                                                                                         [@B102]; [@B28]; [@B71]
  *zim*                                                                                                   tf222a\   G198R\                                                                                                                                                                            
                                                                                                          tm205\    Y139X\                                                                                                                                                                            
                                                                                                          tm206     Allele lost                                                                                                                                                                       
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In addition to *beo*, the *shocked* (*sho*) mutant also shows reduced mobility due to a defect in glycinergic synaptic transmission. The *sho* gene encodes the glycine transporter GlyT1 ([@B57]; [@B215]). Based on its function, the loss-of-function mutation of GlyT1 should increase the availability of extracellular glycine in the CNS. Over-activation of the glycinergic synapse by elevated extracellular glycine can suppress the neural network responsible for motility, and therefore result in a phenotype of reduced mobility. Of note, strychnine, a specific inhibitor of GlyR, partially restores normal neuronal activity in *sho* mutants ([@B57]). Other mutants with reduced mobility have gene mutations unrelated to glycinergic transmission (**Table [3](#T3){ref-type="table"}**).

###### 

Mutants with reduced locomotion.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Mutant            Responsible gene                                                                    Alleles   Substitutions   Cause of defective behavior                                                             References
  ----------------- ----------------------------------------------------------------------------------- --------- --------------- --------------------------------------------------------------------------------------- -----------------------------------
  *sofa potato*\    Acetylcholine receptor δ subunit gene on chromosome 24                              tj19d\    L28P\           Loss of neuromuscular transmission due to defect in acetylcholine receptor clustering   [@B102]; [@B230], [@B231]
  *sop*                                                                                                 ts29\     Unknown\                                                                                                
                                                                                                        tf207c    Unknown                                                                                                 

                                                                                                                                                                                                                          

  *relaxed*\        Dihydropyridine receptor β~1a~ subunit gene (*CACNB1*) on chromosome 3              ts25\     W451X\          Defect in excitation-contraction coupling                                               [@B102]; [@B316]; [@B267]
  *red*                                                                                                 mi90      Y283X                                                                                                   

                                                                                                                                                                                                                          

  *nicotinic*\      Acetylcholine receptor α subunit gene on chromosome 6                               tk48d     Unknown         Loss of neuromuscular transmission due to defect in acetylcholine receptor clustering   [@B102]
  *receptor*\                                                                                                                                                                                                             
  *nic*                                                                                                                                                                                                                   

                                                                                                                                                                                                                          

  *heart attack*\   Unknown                                                                             te313     Unknown         Unknown                                                                                 [@B102]
  *hat*                                                                                                                                                                                                                   

                                                                                                                                                                                                                          

  *herzschlag*\     Titin gene (*ttna*) on chromosome 9                                                 tg287     Unknown         Unknown                                                                                 [@B102]; [@B221]
  *hel*                                                                                                                                                                                                                   

                                                                                                                                                                                                                          

  *unplugged*\      Muscle specific receptor tyrosine kinase gene on chromosome 10                      te314b    Unknown         Defect in initial outgrowth of motor axons                                              [@B102]; [@B179]; [@B148]
  *unp*                                                                                                                                                                                                                   

                                                                                                                                                                                                                          

  *shocked*\        Glycine transporter 1 gene (*slc6a9*) on chromosome 2                               ta51e\    Unknown\        Over-activation of glycinergic synapse by elevated extracellular glycine level          [@B102]; [@B190]; [@B57]; [@B215]
  *sho*                                                                                                 te301\    C893Y\                                                                                                  
                                                                                                        ta229g    G81D                                                                                                    

                                                                                                                                                                                                                          

  *twitch once*\    Acetylcholine receptor clustering factor rapsyn gene (*rapsn*) on chromosome 18     th26e\    G130E\          Loss of neuromuscular transmission due to defect in acetylcholine receptor clustering   [@B102]; [@B232], [@B231]
  *two*                                                                                                 tm335\    Unknown\                                                                                                
                                                                                                        tq265b    Unknown                                                                                                 

                                                                                                                                                                                                                          

  *alligator*\      RING finger protein 121 gene (*rnf121*) on chromosome 21                            tm342\    L39X\           Defect in the excitability of sensory Rohon-Beard neurons                               [@B102]; [@B227]
  *ali*                                                                                                 mi500     V232A                                                                                                   

                                                                                                                                                                                                                          

  *fakir*\          α subunit of voltage-gated calcium channel 2.1b gene (*CACNA1Ab*)on chromosome 11   tm154     L356V           Reduced synaptic transmission between Rohon-Beard neuron and interneuron                [@B102]; [@B189]
  *far*                                                                                                                                                                                                                   

                                                                                                                                                                                                                          

  *macho*\          Pigk gene (*pigk*) on chromosome 2                                                  tt261     M1T             Defect in the excitability of sensory Rohon-Beard neurons                               [@B102]; [@B47]
  *mao*                                                                                                                                                                                                                   

                                                                                                                                                                                                                          

  *steifftier*\     Unknown                                                                             tf220     Unknown         Defect in the excitability of sensory Rohon-Beard neurons                               [@B102]
  *ste*                                                                                                                                                                                                                   

                                                                                                                                                                                                                          

  *crocodile*\      Unknown                                                                             tw212d\   Unknown\        Unknown                                                                                 [@B102]
  *cro*                                                                                                 m148\     Unknown\                                                                                                
                                                                                                        s3556     Unknown                                                                                                 

                                                                                                                                                                                                                          

  *schlaffi*\       Unknown                                                                             ty112\    Unknown\        Unknown                                                                                 [@B102]
  *sla*                                                                                                 th239\    Unknown\                                                                                                
                                                                                                        tg230     Unknown                                                                                                 

                                                                                                                                                                                                                          

  *slumber*\        Unknown                                                                             tt208\    Unknown\        Unknown                                                                                 [@B102]
  *slm*                                                                                                 tm221\    Unknown\                                                                                                
                                                                                                        tm132c    Unknown                                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Defective GlyR Clustering in the *bandoneon* Mutant
---------------------------------------------------

The tubingen mutant screen identified seven mutant alleles (tp221 = Y79X, tw38f = L255R, ta86d = Y79X, ta92 = K343X, tm115 = Q87X, tf242 = Y79D, and tu230 = lost) of *glrbb* ([@B102]; [@B94]). In addition, we have isolated an eighth allele (mi106a = R275H) in a previous mutagenesis screen ([@B129]). These zebrafish *glrbb* mutants were named *bandoneon* after the South American accordion-like instrument. Phenotypically, the *bandoneon* mutations show simultaneous contraction of both axial muscles instead of alternating in response to touch stimuli; therefore, the mutant body length is shortened by tactile stimuli, similar to the movement of an accordion ([@B129]). Since axial muscle contractions are controlled by the reciprocal inhibition of the left and right sides of the spinal cord, inhibitory synaptic transmission is required to produce alternating contractions for swimming ([@B107]; [@B252]). As abovementioned, GlyR clustering at synaptic sites is necessary for effective glycinergic transmission and motor pattern generation. In *bandoneon* mutants, GlyR cluster immunostaining in the spinal cord has a diffuse appearance rather than a clustered appearance, suggesting that GlyRb is necessary for the synaptic aggregation of αβ GlyRs in zebrafish ([@B165]; [@B208]; [@B85]; [@B159]).

Defective GlyT1 in the *shocked* Mutant
---------------------------------------

*Shocked* (*sho*) carries a mutation in *slc6a9*, which encodes GlyT1. Three mutant alleles of *slc6a9* were identified in the Tübingen screen (ta229g = G81D, te301 = C305Y and ta51e = unknown), and these *sho* mutants exhibit trunk twitching instead of swimming in response to tactile stimuli at 2 dpf ([@B102]; [@B190]; [@B57]; [@B215]). In addition, the frequency of spontaneous coiling is reduced and the escape contraction at 1 dpf is abolished in *sho* mutants. An electrophysiological analysis revealed that tactile stimuli induces arrhythmic muscle activation in *sho* mutants rather than the rhythmic depolarization observed in wild-type muscle ([@B58]). The ta229g allele, which produces the strongest phenotype, results from a G81D missense mutation that disrupts GlyT1 function ([@B57]). Increased extracellular glycine is thought to be the cause of the *sho* mutant phenotype. This presumption is supported by the following observations. First, the perfusion of glycine-free cerebrospinal fluid following the removal of the dorsal roof of the fourth ventricle recovers touch-evoked swimming in *sho* mutants, and this effect is lost when glycine is added to the perfusate ([@B57]; [@B215]). Second, the application of low concentrations of strychnine to *sho* mutants leads to partial motor recovery, similar to observations in GlyT1 knockout mice ([@B100]; [@B57]). Thus, a lack of functional GlyT1 and elevated extracellular glycine are likely to underlie the potentiation of glycinergic transmission in the *sho* phenotype.

The GlyT1 knockout mice exhibited severe motor and respiratory defects and die at birth due to the respiratory defect ([@B100]), whereas the GlyT1 defective zebrafishes exhibit a motility recovery by 4--5 dpf and survive thereafter ([@B215]). The motility recovery was accompanied by a reduction in GlyR expression that leads to a decrease in the amplitude of inhibitory potentials enhanced by the GlyT1 mutant ([@B215]). Although the alteration of GlyR expression may represent compensatory mechanisms, the molecular basis for this compensation is not revealed.

Glycinergic transporter 1 dysfunction has been posited in the pathogenesis of glycine encephalopathy, which is characterized by respiratory impairment ([@B100]; [@B8], [@B9]; [@B118]), and schizophrenia which may be arose from hypofunction of NMDAR ([@B172]; [@B177]; [@B287]; [@B62]). Animal models are clearly required to investigate the biological roles of GlyT1 in the context of human disorders, and zebrafish may provide particular advantages in future efforts. For example, while GlyT1 knockout mice die on the first postnatal day due to severe respiratory deficits ([@B100]; [@B287]), zebrafish *sho* mutants can survive well into adulthood through careful feeding and are thus useful as a physiologically relevant animal model for GlyT1 dysfunction.

Conclusion
==========

Functional GlyRs are α homomeric or αβ heteromeric pentamers. Electrophysiological studies of α subunits in cultured cells have shown the difference in conductance and kinetics of each α subunit ([@B283]; [@B35]; [@B245]; [@B25]; [@B197]; [@B39]; [@B315]). Moreover, both in zebrafish and in mammals, each α subunit exhibits a distinct pattern of temporal and spatial expression in the CNS. This diversity of the α subunits suggests that GlyRs play various roles in physiological functions. However, the details of these physiological roles are not well understood. Several studies have identified GlyR subunit selective modulator in Cannabinoids and endocannabinoid ([@B124]; [@B304]; [@B303]), in compounds isolated from ginkgo and Australian marine sponges ([@B19], [@B20],[@B21]; [@B194]). Furthermore, recent publications have reported that heptapeptide exhibit the subunit selective modulating effects on α1β and α3β heteromeric receptor with zinc ion dependence ([@B56]). These subunit-selective modulators would be useful tool to investigate the physiological roles of GlyR subunits in CNS. Together with the selective modulator, losses of function mutants of each GlyR subunit are powerful tools for uncovering the specific functions of each GlyR subunit. Now, zebrafish provide a cheaper, more convenient and highly useful alternative animal model for the study of GlyRs and glycinergic transmission. So far, the *glrbb* and *slc6a9* mutants have been used to investigate the glycinergic synapse. Future work can further utilize CRISPR/Cas9-mediated gene disruption in zebrafish. In addition, *in vivo* observations of the glycinergic synapse in living zebrafish are a powerful method for the study of glycinergic synapse formation and plasticity. Taken together, a combination of readily available genetic mutants and innovative imaging techniques in zebrafish is sure to accelerate our understanding of glycinergic neurotransmission in the future.
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